Angie Godinez, Author at Bioscience Americas

May 2017

What Are the Unique Properties of All Stem Cells?

Stem cells differ from other kinds of cells in the body. All stem cells—regardless of their source—have three general properties: they are capable of dividing and renewing themselves for long periods; they are unspecialized; and they can give rise to specialized cell types. Stem cells are capable of dividing and renewing themselves for long periods. Unlike muscle cells, blood cells, or nerve cells—which do not normally replicate themselves—stem cells may replicate many times, or proliferate. A starting population of stem [...]

April 2017

What Are Stem Cells and Why Are They Important?

Stem Cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more [...]

March 2017

Today is Diabetes Alert Day!

Today is American Diabetes Association Alert Day. More than 29 million Americans have diabetes; of those, nearly 8 million don’t know they have the disease. Today marks the American Diabetes Association’s 29th annual Alert Day, an opportunity to sound the alarm about the prevalence and risks of type 2 diabetes by asking Americans to take our Type 2 Diabetes Risk Test. The free, anonymous risk test only takes a minute to complete and is available online at By answering questions [...]

Stem Cells for Long-Term Remission of Multiple Sclerosis

New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis (MS), an autoimmune disease in which the immune system attacks the central nervous system. Five years after receiving the treatment, called high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT), 69 percent of trial participants had survived without experiencing progression of disability, relapse of MS symptoms or new brain lesions. Notably, participants [...]

February 2017

The High Cost of Diabetes

According to the American Diabetes Association, nearly 30 million Americans have diabetes. Another 86 million have prediabetes. Diabetes and prediabetes cost the United States more than $322 billion per year. 1 in every 5 health care dollar is spent caring for people with diabetes. 1 in every 3 Medicare dollar is spent caring for people diagnosed with diabetes. Not only is the market substantial but it is growing. Twenty years ago the percentage of the U.S. population diagnosed with diabetes was [...]

January 2017

Benefits of Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are advantageous over other stem cells types for a variety of reasons. First, they avoid the ethical issues that surround embryonic stem cell research. Second, repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogeneic transplantation. MSCs reduce both the risks of rejection and complications of transplantation. Third, there have been advances in the use of autologous mesenchymal stem cells to regenerate human tissues, including cartilage, meniscus, tendons, and bone [...]

Is Stem Cell Therapy Safe?

What do we know of the safety and efficacy of stem cell therapeutics? We are indebted to Cade Hildreth, CEO of BioInformant for this article and information. Over 50 years have passed since the discovery of hematopoietic stem cells (bone marrow transplantation to cure diseases such as leukemia), almost 20 years since the discovery of human embryonic stem cells (hESC), and 10 years since the discovery of induced pluripotent stem cells (iPS cells). There are also more than 5,000 stem cell [...]

Dr. Shekhar Challa Joins Bioscience Americas Board of Advisors

Bioscience Americas, LLC, a leading developer of autologous stem cell treatment centers, is pleased to announce that Dr. Shekhar K. Challa has joined its Board of Advisors. Dr. Challa is the co-founder of the Kansas Medical Clinic in Topeka, Kansas. The Clinic is a multi-specialty facility focused on gastroenterology, dermatology, pathology, and plastic surgery. Dr. Challa received his MD degree from Kakatiya Medical College in Andhra Pradesh, India. His internship and residency and fellowship were completed at Coney Island [...]

Bioscience Americas Names Dr. Firas Kara to its Board of Advisors

Bioscience Americas is pleased to announce that Dr. Firas M. Kara of Fort Wayne, Indiana has joined the Bioscience Americas Board of Advisors. Dr. Kara holds duel MD and PhD degrees from Heinrich Heine University in Düsseldorf, Germany. He completed a Residency in Internal Medicine at Berkshire Medical Center/ University of Massachusetts Medical School. Dr. Kara is currently specializing in interventional pain management with an emphasis on non-operative spine care. He believes in a comprehensive, compassionate approach to patient [...]

December 2016

President Obama Signs 21st Century Cures Act into Law

We are pleased to announce that President Obama signed the 21st Century Cures Act into law, authorizing $6.3 billion in funding. In an emotional signing that is likely to be the last of his presidency, President Obama stated, “Let’s make American the country to solve cancer.” Previously, the bill was approved 392-26 by the House of Representatives and 94-5 in the U.S. Senate. Importantly, the bill puts the U.S. on the same playing field as many other developed countries, including [...]